SIG
52
5
HRB
40
3
VMC
41
2
VFC
56
6
CCI
30
2
AFL
34
6
CCL
68
6
EXR
42
5
SJM
17
5
CAT
47
3
ADI
54
4
MKC
54
3
MAS
46
3
MET
58
2
AMP
43
2
NTAP
58
3
ADBE
50
3
FSLR
50
6
PFE
37
4
ECL
54
5
SIG
52
5
HRB
40
3
VMC
41
2
VFC
56
6
CCI
30
2
AFL
34
6
CCL
68
6
EXR
42
5
SJM
17
5
CAT
47
3
ADI
54
4
MKC
54
3
MAS
46
3
MET
58
2
AMP
43
2
NTAP
58
3
ADBE
50
3
FSLR
50
6
PFE
37
4
ECL
54
5
Financhill
Back

Molecular Partners AG 10K Form

Sell
28

MOLN
Molecular Partners AG

Last Price:
$5.18
Seasonality Move:
-1.41%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MOLN News And Ratings

See the #1 stock for the next 7 days that we like better than MOLN

MOLN Financial Statistics

Sales & Book Value

Annual Sales: $7.8M
Cash Flow: $-17.3M
Price / Cash Flow: 0
Annual Sales: $4.97
Price / Book: 1.13

Profitability

EPS (TTM): -2.14130
Net Income (TTM): $-70.9M
Gross Margin: --
Return on Equity: -37.36%
Return on Assets: -33.67%

Molecular Partners AG Earnings Forecast

Key Molecular Partners AG Financial Ratios

  • The Research & Development expenses have been 693.15% of Revenue.
  • The Interest Expense is -0.05% of Operating Income.
  • The Net Earning history of MOLN is -880.71% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Molecular Partners AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MOLN
Website: molecularpartners.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.33
Quick Ratio: 14.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MOLN Technical Analysis vs Fundamental Analysis

Sell
28
Molecular Partners AG (MOLN) is a Sell

Is Molecular Partners AG a Buy or a Sell?